Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$886M |
| 2 |
Chevron
CVX
|
+$595M |
| 3 |
Union Pacific
UNP
|
+$360M |
| 4 |
Baxter International
BAX
|
+$276M |
| 5 |
Xcel Energy
XEL
|
+$252M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$520M |
| 2 |
NXP Semiconductors
NXPI
|
+$248M |
| 3 |
Oracle
ORCL
|
+$242M |
| 4 |
Amgen
AMGN
|
+$197M |
| 5 |
Eli Lilly
LLY
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.12% |
| 2 | Technology | 7.86% |
| 3 | Healthcare | 6.8% |
| 4 | Industrials | 5.01% |
| 5 | Consumer Discretionary | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCN
3576
Waste Connections
WCN
$41.4B
| $2.24M | ﹤0.01% |
16,589
-566,678
| -97% | -$77.3M |
|
3577
Textron
TXT
$15.1B
| $2.24M | ﹤0.01% |
38,394
-108,828
| -74% | -$6.9M |
|
3578
iShares MSCI EAFE Value ETF
EFV
$29.2B
| $2.23M | ﹤0.01% |
+57,921
| New | +$2.47M |
|
|
CERO
3579
DELISTED
CERo Therapeutics
CERO
| $2.23M | ﹤0.01% |
111
| – | – |
|
3580
Allegro MicroSystems
ALGM
$8.07B
| $2.23M | ﹤0.01% |
102,086
-476,221
| -82% | -$11.1M |
|
3581
Praxis Precision Medicines
PRAX
$10.4B
| $2.23M | ﹤0.01% |
65,463
+46,990
| +254% | +$2.34M |
|
|
DISH
3582
PUT
DELISTED
DISH Network Corp.
DISH
| $2.23M | ﹤0.01% |
161,200
-146,100
| -48% | -$2.58M |
|
3583
CALL
Spotify
SPOT
$97.8B
| $2.23M | ﹤0.01% |
25,800
| – | – |
|
|
WHWK
3584
Whitehawk Therapeutics
WHWK
$218M
| $2.23M | ﹤0.01% |
157,616
+127,652
| +426% | +$1.68M |
|
3585
ALX Oncology
ALXO
$262M
| $2.22M | ﹤0.01% |
232,162
-197,118
| -46% | -$2.3M |
|
|
EDTX
3586
DELISTED
EdtechX Holdings Acquisition Corp. II Class A common stock
EDTX
| $2.22M | ﹤0.01% |
217,000
| – | – |
|
3587
SiriusPoint
SPNT
$2.75B
| $2.22M | ﹤0.01% |
448,109
+423,912
| +1,752% | +$1.97M |
|
|
HTB
3588
HomeTrust Bancshares
HTB
$861M
| $2.21M | ﹤0.01% |
100,060
+67,976
| +212% | +$1.64M |
|
|
ARRWU
3589
DELISTED
Arrowroot Acquisition Corp. Unit
ARRWU
| $2.21M | ﹤0.01% |
225,326
| – | – |
|
|
FRG
3590
DELISTED
Franchise Group, Inc.
FRG
| $2.2M | ﹤0.01% |
90,584
-52,569
| -37% | -$1.73M |
|
3591
WisdomTree Floating Rate Treasury Fund
USFR
$18.4B
| $2.2M | ﹤0.01% |
+43,754
| New | +$2.2M |
|
3592
Bristol-Myers Squibb
BMY
$130B
| $2.2M | ﹤0.01% |
30,925
-314,845
| -91% | -$22.8M |
|
3593
Globant
GLOB
$1.6B
| $2.2M | ﹤0.01% |
11,743
-103,087
| -90% | -$21.3M |
|
3594
Neuropace
NPCE
$473M
| $2.19M | ﹤0.01% |
585,367
+78,462
| +15% | +$378K |
|
|
VZIO
3595
DELISTED
VIZIO Holding Corp.
VZIO
| $2.19M | ﹤0.01% |
250,784
-242,816
| -49% | -$2.44M |
|
3596
PUT
Credit Acceptance
CACC
$6.08B
| $2.19M | ﹤0.01% |
5,000
-2,500
| -33% | -$1.32M |
|
3597
Corcept Therapeutics
CORT
$11.7B
| $2.19M | ﹤0.01% |
85,252
-528,757
| -86% | -$14.1M |
|
3598
CALL
Hasbro
HAS
$12.9B
| $2.18M | ﹤0.01% |
32,400
+8,200
| +34% | +$648K |
|
|
VHAQ
3599
DELISTED
Viveon Health Acquisition Corp.
VHAQ
| $2.18M | ﹤0.01% |
210,830
-8,121
| -4% | -$83.9K |
|
3600
CALL
ResMed
RMD
$32.6B
| $2.18M | ﹤0.01% |
10,000
+7,000
| +233% | +$1.59M |
|
Similar funds
Millennium Management's Q3 2022 Portfolio in Review
As of Q3 2022, Millennium Management held 7,917 positions worth $169B, up 4.9% from $161B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $14.7B of net new capital in Q3 2022, opening 1,007 new positions and adding to 2,598 existing holdings. Its largest new stake was Rockwell Automation: 953,525 shares worth $205M.
By sector, the portfolio is most concentrated in Financials at 8.1% of assets, up from 7.6% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $520M trimmed.
- Millennium Management's largest Q3 2022 buy was Rockwell Automation: 953,525 shares worth $205M.
- Millennium Management added most to Duke Realty Corp. in Q3 2022, an estimated $886M increase.
- Millennium Management's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $520M.
- Millennium Management fully exited Coherent Inc in Q3 2022, selling an estimated $114M.
- Millennium Management's ten largest holdings make up 23% of its $169B portfolio in Q3 2022.
- Millennium Management opened 1,007 new positions and closed 906 in Q3 2022.
- Millennium Management's portfolio value rose 4.9% quarter-over-quarter to $169B.
Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.